| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to reviewers
|
|
|
|
69 |
3 |
p. 495-499
|
artikel
|
| 2 |
Acknowledgement to reviewers
|
|
|
|
69 |
3 |
p. 495-499
|
artikel
|
| 3 |
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
|
Boudewijns, Steve
|
|
|
69 |
3 |
p. 477-488
|
artikel
|
| 4 |
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
|
Bergenfelz, Caroline
|
|
|
69 |
3 |
p. 435-448
|
artikel
|
| 5 |
Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study
|
Zhang, Guowei
|
|
|
69 |
3 |
p. 399-405
|
artikel
|
| 6 |
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
|
Thomas, Remy
|
|
|
69 |
3 |
p. 449-463
|
artikel
|
| 7 |
Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
|
Ma, Junxun
|
|
|
69 |
3 |
p. 365-372
|
artikel
|
| 8 |
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
|
Bains, Simer J.
|
|
|
69 |
3 |
p. 355-364
|
artikel
|
| 9 |
Lung cancer-derived extracellular vesicles: a possible mediator of mast cell activation in the tumor microenvironment
|
Salamon, Pazit
|
|
|
69 |
3 |
p. 373-381
|
artikel
|
| 10 |
Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas
|
Roussel, Mikael
|
|
|
69 |
3 |
p. 407-420
|
artikel
|
| 11 |
PCSK9 is a promising prognostic marker in patients with advanced NSCLC
|
Bonaventura, Aldo
|
|
|
69 |
3 |
p. 491-492
|
artikel
|
| 12 |
PD-L1 expression levels should be considered when identifying risk factors in NSCLC patients treated with nivolumab
|
Li, Pengfei
|
|
|
69 |
3 |
p. 489
|
artikel
|
| 13 |
Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cells
|
Su, Zhaoliang
|
|
|
69 |
3 |
p. 493
|
artikel
|
| 14 |
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide
|
Sarkar, Subhashis
|
|
|
69 |
3 |
p. 421-434
|
artikel
|
| 15 |
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
|
Wilson, Brooke E.
|
|
|
69 |
3 |
p. 343-354
|
artikel
|
| 16 |
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction
|
Quan, Hongzhi
|
|
|
69 |
3 |
p. 465-476
|
artikel
|
| 17 |
The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
|
Patel, Akshay J.
|
|
|
69 |
3 |
p. 325-342
|
artikel
|
| 18 |
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
|
Battaglia, Alessandra
|
|
|
69 |
3 |
p. 383-397
|
artikel
|
| 19 |
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
|
Battaglia, Alessandra
|
|
|
69 |
3 |
p. 383-397
|
artikel
|
Tijdschrift beschrijving